NBC has ordered a second season of hit Canadian medical drama Transplant. The network acquired the drama series in May, weeks into the COVID-19 production shutdown, and it has been a huge success ratings-wise.In its first season on NBC, Transplant has averaged a 0.7 rating in adults 18-49 and 5.7 million viewers overall in Live+7, with the premiere having grown to a 1.8 in 18-49 with digital and linear viewing.
The series has scored as one of television’s most time-shifted shows through its NBC run, with each of its first seven original telecasts ranking as the No.
1 drama of the week in Live+3. In linear and digital viewing to date, Transplant is averaging 7.7 million total viewers, more than doubling its 3.5 million in L+Same Day.In its
Read more on deadline.com